GAUDIUM IVF N WOMEN H L Latest Share Price (GAUDIUMIVF)
TODAY IN ONE LINE
GAUDIUMIVF dropped 3.8%, lagging Nifty's -1.1% move, with no exchange filing today, suggesting a market-driven move.
With a market cap of ₹722.05 Cr., it trades at a P/E of 29.52. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
GAUDIUM IVF N WOMEN H L flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●High Capital EfficiencyROCE of 21.6% indicating pricing power
- ●Strong Return on EquityHealthy ROE of 20.7%
- ●Healthy Operating MarginsOPM is structurally strong at 48.9%
- ●High Promoter HoldingPromoters hold 71.3% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.14x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●FII SellingFII holding decreased by 1.83% QoQ
Latest GAUDIUM IVF N WOMEN H L News
What changed recently?
Recent events, corporate actions, and announcements.
GAUDIUM IVF N WOMEN H L valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for GAUDIUM IVF N WOMEN H L, framed against the sector median so the premium or discount is obvious at a glance.
GAUDIUM IVF N WOMEN H L trades at a P/E of 29.52× and P/B of 4.74×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
GAUDIUM IVF N WOMEN H L technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for GAUDIUM IVF N WOMEN H L — derived from the latest tape, not yesterday's close.
GAUDIUM IVF N WOMEN H L last traded at ₹97.58 with an intraday range of ₹96.11–₹102.72 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹97.58| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 114.72 | +17.14 | +17.56% |
| R3 | 108.11 | +10.53 | +10.79% |
| R2 | 105.41 | +7.83 | +8.03% |
| R1 | 101.50 | +3.92 | +4.01% |
| PIVOT | 98.80 | 1.22 | 1.25% |
| CURRENT | 97.58 | — | — |
| S1 | 94.89 | -2.69 | -2.76% |
| S2 | 92.19 | -5.39 | -5.52% |
| S3 | 88.28 | -9.30 | -9.53% |
| S4 | 81.67 | -15.91 | -16.31% |
GAUDIUMIVF is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹100–₹102.72
Trading Below opening range, showing Bearishness
GAUDIUM IVF N WOMEN H L financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for GAUDIUM IVF N WOMEN H L — consolidated or standalone — with margins, YoY growth and key ratios inline.
GAUDIUM IVF N WOMEN H L reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹722.05 Cr. and reported EPS of ₹0.24.
| Metric | Mar 2026 | May 2026 |
|---|---|---|
| Revenue from Operations | 104 | 104 ▲ 0.0% |
| Other Income | 1 | 1 ▲ 0.0% |
| Total Income | 105 | 105 ▲ 0.0% |
| 34 | 34 ▲ 0.0% | |
| Gross ProfitDerived | 71 | 71 ▲ 0.0% |
| Gross Margin %Derived | 67.80% | 67.80% |
| 33 | 33 ▲ 0.0% | |
| EBITDA (Operating Profit)Derived | 38 | 38 ▲ 0.0% |
| OPM %Derived | 36.13% | 36.13% |
| 6 | 6 ▲ 0.0% | |
| Profit Before Tax (PBT) | 32 | 32 ▲ 0.0% |
| 8 | 8 ▲ 0.0% | |
| Effective Tax %Derived | 23.94% | 23.94% |
| Profit/Loss from Discontinued Ops | -0 | -0 ▲ 0.0% |
| Total Profit for Period | 24 | 24 ▲ 0.0% |
| Net Profit (Owner's PAT)Derived | 24 | 24 ▲ 0.0% |
| Net Profit Margin %Derived | 23.47% | 23.47% |
| Earnings Per Share (EPS ₹) | 3.36 | 3.36 ▲ 0.0% |
| Diluted Shares Outstanding (Cr) | 7 | 7 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | 0 | 0 ▲ 0.0% |
| Total Expenses (incl. D&A & Interest) | 73 | 73 ▲ 0.0% |
| Material Cost % of RevenueDerived | — | — |
| Employee Cost % of RevenueDerived | 7.65% | 7.65% |
| Other Cost % of RevenueDerived | 24.02% | 24.02% |
| Interest Coverage (x)Derived | 10.07x | 10.07x |
| Period | Mar 2026 | May 2026 | Trend |
|---|---|---|---|
| Revenue from Operations | 104 | 104 ▲ 0.0% | |
| Other Income | 1 | 1 ▲ 0.0% | |
| Total Income | 105 | 105 ▲ 0.0% | |
34 | 34 ▲ 0.0% | ||
| Gross ProfitDerived | 71 | 71 ▲ 0.0% | |
| Gross Margin %Derived | 67.80% | 67.80% | |
33 | 33 ▲ 0.0% | ||
| EBITDA (Operating Profit)Derived | 38 | 38 ▲ 0.0% | |
| OPM %Derived | 36.13% | 36.13% | |
6 | 6 ▲ 0.0% | ||
| Profit Before Tax (PBT) | 32 | 32 ▲ 0.0% | |
8 | 8 ▲ 0.0% | ||
| Effective Tax %Derived | 23.94% | 23.94% | |
| Profit/Loss from Discontinued Ops | -0 | -0 ▲ 0.0% | |
| Total Profit for Period | 24 | 24 ▲ 0.0% | |
| Net Profit (Owner's PAT)Derived | 24 | 24 ▲ 0.0% | |
| Net Profit Margin %Derived | 23.47% | 23.47% | |
| Earnings Per Share (EPS ₹) | 3.36 | 3.36 ▲ 0.0% | |
| Diluted Shares Outstanding (Cr) | 7 | 7 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | 0 | 0 ▲ 0.0% | |
| Total Expenses (incl. D&A & Interest) | 73 | 73 ▲ 0.0% | |
| Material Cost % of RevenueDerived | — | — | |
| Employee Cost % of RevenueDerived | 7.65% | 7.65% | |
| Other Cost % of RevenueDerived | 24.02% | 24.02% | |
| Interest Coverage (x)Derived | 10.07x | 10.07x |
GAUDIUM IVF N WOMEN H L segment analysis : revenue and profit mix.
Disclosed business segments at GAUDIUM IVF N WOMEN H L with their share of revenue and profit, switchable between consolidated and standalone reporting.
GAUDIUM IVF N WOMEN H L discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for GAUDIUM IVF N WOMEN H L.
Our AI distills the core fundamental drivers supporting GAUDIUM IVF N WOMEN H L, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
What you're getting.
No strengths or opportunities on record.
Key Risks.
No weaknesses or threats on record.
Flip Conditions.
Valuation risk. a P/E above 38 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 16% would indicate weaker capital compounding.
GAUDIUM IVF N WOMEN H L peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — GAUDIUM IVF N WOMEN H L is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
GAUDIUM IVF N WOMEN H L chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for GAUDIUM IVF N WOMEN H L — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
GAUDIUM IVF N WOMEN H L delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for GAUDIUM IVF N WOMEN H L over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in GAUDIUM IVF N WOMEN H L stood at 50.3% of traded volume, against a 20-day average of 53.6%.
GAUDIUM IVF N WOMEN H L announcements: results, concalls, ratings, M&A.
Filings GAUDIUM IVF N WOMEN H L sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
GAUDIUM IVF N WOMEN H L files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 47 documents below.
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended…
Shareholders meeting
Gaudium IVF and Women Health Limited has submitted the Exchange the Voting Results and Consolidated Scrutinizers Report of the 11th Annual General…
Shareholders meeting
Gaudium IVF and Women Health Limited has informed the Exchange regarding Proceedings of 11th Annual General Meeting of the Company held on Monday,…
Trading Window
Gaudium IVF and Women Health Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading)…
Commencement of commercial production/operations
Gaudium IVF and Women Health Limited has informed the Exchange about commencement of commercial operations at Company's new IVF Centre/Hub at…
Investor decks & rating reports.
GAUDIUM IVF N WOMEN H L dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue GAUDIUM IVF N WOMEN H L has declared, sequenced by announce and record date.
GAUDIUM IVF N WOMEN H L corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About GAUDIUM IVF N WOMEN H L: business, sector, key facts.
What GAUDIUM IVF N WOMEN H L does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
GAUDIUM IVF N WOMEN H L is a listed Indian equity, listed as NSE: GAUDIUMIVF, BSE: 544709.
GAUDIUM IVF N WOMEN H L
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B BLACKBIO DX (3BBLACKBIO) Share PricePeer
- ABBOTT INDIA (ABBOTINDIA) Share PricePeer
- ACUTAAS CHEMICALS (ACUTAAS) Share PricePeer
- ANLON HEALTHCARE (AHCL) Share PricePeer
- AMANTA (AMANTA) Share PricePeer
- Top Losers TodayScreener
- Top quality scorecard stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about GAUDIUM IVF N WOMEN H L (GAUDIUMIVF).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of GAUDIUM IVF N WOMEN H L (GAUDIUMIVF)?
The current share price of GAUDIUM IVF N WOMEN H L (GAUDIUMIVF) is ₹97.58. Today, the stock has declined by ₹3.88 (3.82%), trading in a range of ₹96.11 to ₹102.72. The stock opened at ₹102.12 with a trading volume of 2,19,645 shares.
02Is GAUDIUM IVF N WOMEN H L stock a good investment for long-term?
GAUDIUM IVF N WOMEN H L can be considered for long-term investment based on several factors. The company has a market capitalization of ₹722.05 Cr., P/E ratio of 29.52, ROE of 20.72%, and ROCE of 21.57%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of GAUDIUM IVF N WOMEN H L stock?
The 52-week high price of GAUDIUM IVF N WOMEN H L (GAUDIUMIVF) is ₹133.00, while the 52-week low is ₹69.18. Currently trading at ₹97.58, the stock is 41.05% above its 52-week low and 26.63% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy GAUDIUM IVF N WOMEN H L stock at the current price?
Whether to buy GAUDIUM IVF N WOMEN H L stock at ₹97.58 depends on multiple factors. The stock is currently trading with a P/E ratio of 29.52 and P/B ratio of 4.74. Today's performance shows a loss of 3.82%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of GAUDIUM IVF N WOMEN H L and when is the next dividend?
GAUDIUM IVF N WOMEN H L offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹97.58, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹5.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of GAUDIUM IVF N WOMEN H L?
GAUDIUM IVF N WOMEN H L's key financial metrics include: P/E Ratio: 29.52, P/B Ratio: 4.74, ROE: 20.72%, ROCE: 21.57%, Dividend Yield: 0%, EPS: ₹0.24, Book Value: ₹20.92, and Debt-to-Equity: 0.14. The company's market cap stands at ₹722.05 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is GAUDIUM IVF N WOMEN H L stock performing today in the market?
GAUDIUM IVF N WOMEN H L stock opened at ₹102.12 and is currently trading at ₹97.58, showing a decline of ₹3.88 (3.82%). The intraday high is ₹102.72 and low is ₹96.11. The trading volume stands at 2,19,645 shares, indicating moderate market participation today.
08What is the P/E ratio of GAUDIUM IVF N WOMEN H L and what does it indicate?
GAUDIUM IVF N WOMEN H L has a Price-to-Earnings (P/E) ratio of 29.52, which means investors are willing to pay 29.52 for every ₹1 of earnings. With an EPS of ₹0.24, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about GAUDIUM IVF N WOMEN H L (GAUDIUMIVF) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.